| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EJSO.2006.10.040 |
| P698 | PubMed publication ID | 17174059 |
| P2093 | author name string | Maurer CA | |
| Lange J | |||
| Hartl U | |||
| Abitabile P | |||
| P433 | issue | 1 | |
| P304 | page(s) | 67-71 | |
| P577 | publication date | 2006-12-13 | |
| P1433 | published in | European Journal of Surgical Oncology | Q2345728 |
| P1476 | title | Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. | |
| P478 | volume | 33 |
| Q48161122 | "Edgeboost": A Novel Technique to Extend the Ablation Zone Lateral to a Two-Probe Bipolar Radiofrequency Device. |
| Q33937325 | Ablative therapies for colorectal liver metastases: a systematic review |
| Q42129868 | Accomplishments in 2007 in the management of curable metastatic colorectal cancer |
| Q41553226 | Assessment of thermal sensitivity of CT during heating of liver: an ex vivo study |
| Q34280738 | Case Study of Hepatic Radiofrequency Ablation Causing a Systemic Inflammatory Response Under Total Intravenous Anesthesia |
| Q46862651 | Cetuximab in combination with 5-fluorouracil, leucovorin and irinotecan as a neoadjuvant chemotherapy in patients with initially unresectable colorectal liver metastases |
| Q98386887 | Clinical impact of radiofrequency ablation and stereotactic body radiation therapy for colorectal liver metastasis as local therapies for elderly, vulnerable patients |
| Q40578581 | Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions. |
| Q37581367 | Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases |
| Q38873860 | Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases |
| Q36828555 | Current oncologic applications of radiofrequency ablation therapies |
| Q38755742 | Defining the Optimal Use of Ablation for Metastatic Colorectal Cancer to the Liver Without High-Level Evidence |
| Q52905948 | Determination of the temperature-dependent electric conductivity of liver tissue ex vivo and in vivo: Importance for therapy planning for the radiofrequency ablation of liver tumours. |
| Q42145925 | Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases? |
| Q40364348 | Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma |
| Q41934918 | Evaluation of YO-PRO-1 as an early marker of apoptosis following radiofrequency ablation of colon cancer liver metastases |
| Q46011640 | Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. |
| Q35188617 | Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis |
| Q37522219 | Impact of treatment modality and number of lesions on recurrence and survival outcomes after treatment of colorectal cancer liver metastases |
| Q33587685 | Interventional procedures for hepatic metastases |
| Q31030760 | Interventional therapies of unresectable liver metastases |
| Q42590895 | Lack of Anatomical Concordance between Preablation and Postablation CT Images: A Risk Factor Related to Ablation Site Recurrence. |
| Q37530649 | Liver ablation techniques: a review. |
| Q37657373 | Liver tumor ablation: percutaneous and open approaches |
| Q38256165 | Liver-directed therapies in metastatic colorectal cancer |
| Q40317208 | Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status. |
| Q27006832 | Multi-modality treatment of colorectal liver metastases |
| Q38398883 | Non-operative therapies for colorectal liver metastases |
| Q37530665 | Outcomes of ablation versus resection for colorectal liver metastases: are we comparing apples with oranges? |
| Q51257827 | Percutaneous radiofrequency ablation (RFA) or robotic radiosurgery (RRS) for salvage treatment of colorectal liver metastases. |
| Q38791333 | Planned Treatment of Advanced Metastatic Disease with Completion Ablation After Hepatic Resection |
| Q46343940 | Power Doppler ultrasonography with time-signal intensity curves in monitoring hepatocellular carcinoma and liver metastases after intralesional therapy |
| Q37857524 | Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin |
| Q35201716 | Radiofrequency ablation for treating liver metastases from a non-colorectal origin |
| Q45979072 | Radiofrequency ablation of colorectal liver metastases in a transplanted liver. |
| Q38082982 | Radiofrequency ablation of liver metastases from colorectal cancer: a literature review |
| Q39784584 | Radiofrequency ablation of liver tumors: Actual limitations and potential solutions in the future |
| Q37313076 | Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? |
| Q47414466 | Radiological estimation of size in colorectal liver metastases: is it reliable? Comparison with post-resectional measurements. |
| Q90478112 | Stereotactic body radiation therapy and radiofrequency ablation for the treatment of liver metastases: How and when? |
| Q42429760 | Surgical options for initially unresectable colorectal liver metastases |
| Q37605916 | The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer |
| Q36258276 | Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013 |
| Q35181143 | Thermal ablation of liver metastases from colorectal cancer: radiofrequency, microwave and laser ablation therapies |
| Q48472317 | Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection. |
| Q37392026 | Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases |
Search more.